People: Dyax Corp (DYAX.O)

DYAX.O on Consolidated Issue listed on NASDAQ Global Market

26.31USD
2 Jul 2015
Change (% chg)

$-0.33 (-1.24%)
Prev Close
$26.64
Open
$26.79
Day's High
$26.79
Day's Low
$26.16
Volume
548,976
Avg. Vol
1,476,624
52-wk High
$30.55
52-wk Low
$8.09

Search Stocks

Migausky, George 

Mr. George V. Migausky is Chief Financial Officer and Executive Vice President of Dyax Corp., since 2008. Prior to joining Dyax, he served as CFO of Wellstat Management Company, a privately-held company responsible for the strategy, business development and operations of an affiliated group of five life science companies. From 1990 to 2004, Mr. Migausky served as CFO at IGEN International where he was instrumental in preparing the Company for its initial public offering in 1994, its merger with F. Hoffman La Roche in 2004 and the simultaneous spinoff of BioVeris Corporation as an independent public company. He then served as CFO of BioVeris through to 2008. Mr. Migausky received a Master of Business Administration from Babson College and a Bachelors of Science from Boston College.

Basic Compensation

Total Annual Compensation, USD 391,883
Restricted Stock Awards, USD 244,800
Long-Term Incentive Plans, USD 205,200
All Other, USD 952,109
Fiscal Year Total, USD 1,793,990

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Henry Blair

1,459,040

Gustav Christensen

3,604,950

George Migausky

1,793,990

Andrew Ashe

1,742,660

Burt Adelman

2,576,930

Todd Bazemore

1,527,500
As Of  30 Dec 2014
Search Stocks